West Pharmaceutical Services SG&A Expense (Annual) Insights

West Pharmaceutical Services Inc (WST)

311.00 +3.86 (+1.26%) USD | NYSE | Sep 27, 16:00

311.00 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1984. Upgrade now.

Date	Value
December 31, 2023	353.40M
December 31, 2022	316.90M
December 31, 2021	362.80M
December 31, 2020	302.00M
December 31, 2019	272.70M
December 31, 2018	262.90M
December 31, 2017	246.00M
December 31, 2016	239.60M
December 31, 2015	243.90M
December 31, 2014	228.70M
December 31, 2013	234.90M
December 31, 2012	218.10M
December 31, 2011	191.10M
December 31, 2010	187.70M
December 31, 2009	177.70M
December 31, 2008	159.30M
December 31, 2007	152.50M
December 31, 2006	147.80M
December 31, 2005	115.10M
December 31, 2004	105.20M

Date	Value
December 31, 2003	91.10M
December 31, 2002	67.60M
December 31, 2001	72.00M
December 31, 2000	59.50M
December 31, 1999	77.90M
December 31, 1998	70.50M
December 31, 1997	70.20M
December 31, 1996	72.80M
December 31, 1995	69.90M
December 31, 1994	69.00M
December 31, 1993	63.50M
December 31, 1992	57.10M
December 31, 1991	85.00M
December 31, 1990	57.80M
December 31, 1989	45.60M
December 31, 1988	41.50M
December 31, 1987	32.20M
December 31, 1986	29.90M
December 31, 1985	26.60M
December 31, 1984	23.70M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

272.70M

Minimum

2019

362.80M

Maximum

2021

321.56M

Average

316.90M

Median

2022

SG&A Expense (Annual) Benchmarks